REXAHN PHARMACEUTICALS: A YEAR-IN-REVIEW
From a public company merger to the orphan drug designation of one of its leading
cancer drug candidates, Rexahn Pharmaceuticals, (RXHN.OB), a clinical stage
pharmaceutical company, has much to be proud of as it reflects on 2005 and looks
forward to the year ahead. Based in Rockville, Maryland, Rexahn is a pharmaceutical
company dedicated to the discovery, development, and commercialization of innovative
treatments for cancer and disorders of the central nervous system.
Genetic Engineering News